Prominent psychiatric comorbidity in the dominantly inherited movement disorder myoclonus-dystonia

Parkinsonism and Related Disorders

Volumn 19, Issue 4, 2013, Pages 422-425

  Weissbach, Anne ^a   Kasten, Meike ^a   Grünewald, Anne ^a   Brüggemann, Norbert ^a   Trillenberg, Peter ^a   Klein, Christine ^a   Hagenah, Johann ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Epsilon sarcoglycan gene (SGCE); Literature review; Myoclonus dystonia (M D); Psychiatric disorders

Indexed keywords

EPSILON SARCOGLYCAN;

ADOLESCENT; ADULT; AGED; AGORAPHOBIA; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; BRACHIAL DYSTONIA; CERVICAL DYSTONIA; CHILD; CLINICAL ARTICLE; COMORBIDITY; DEPENDENT PERSONALITY DISORDER; DEPRESSION; DSM-IV; DYSTHYMIA; EPSILON SARCOGLYCAN GENE; FEMALE; GENE MUTATION; HEROIN DEPENDENCE; HUMAN; MALE; MENTAL DISEASE; MYOCLONUS; MYOCLONUS DYSTONIA; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRIORITY JOURNAL; SCHOOL CHILD; SOCIAL PHOBIA; SUBSTANCE ABUSE; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; CHILD; COMORBIDITY; DYSTONIC DISORDERS; FEMALE; HETEROZYGOTE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; SARCOGLYCANS;

EID: 84875237077     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.12.004     Document Type: Article

References (30)

1. Warner T.T., Bressmann S.B. Clinical diagnosis and management of dystonia 2007, Informa Healthcare, London, p. 16.
2. Foncke E.M., Cath D., Zwinderman K., Smit J., Schmand B., Tijssen M. Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia?: a study of a large Dutch M-D family. Cogn Behav Neurol 2009, 22:127-133.
3. Peall K.J., Waite A.J., Blake D.J., Owen M.J., Morris H.R. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review. Mov Disord 2011, 26:1939-1942.
4. Saunders-Pullman R., Shriberg J., Heiman G., Raymond D., Wendt K., Kramer P., et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002, 58:242-245.
5. Klein C. Myoclonus and myoclonus-dystonias. Genetics of movement disorders 2003, 451-471. Academic Press. S.M. Pulst (Ed.).
6. Mahloudji M., Pikielny R.T. Hereditary essential myoclonus. Brain 1967, 90:669-674.
7. Frucht S.J., Leurgans S.E., Hallett M., Fahn S. The unified myoclonus rating scale. Adv Neurol 2002, 89:361-376.
8. Burke R.E., Fahn S., Marsden C.D., Bressman S.B., Moskowitz C., Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985, 35:73-77.
9. Wissel J., Kabus C., Wenzel R., Klepsch S., Schwarz U., Nebe A., et al. Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 1996, 61:172-175.
10. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 1997, 12:100-102.
11. Graubner B. Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitssysteme 2012, Deutscher Ärzte Verlag, Göttingen, ICD-10 GM 2012.
12. Kessler R.C., Ustun T.B. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004, 13:93-121.
13. Leentjens A.F., Verhey F.R., Luijckx G.J., Troost J. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 2000, 15:1221-1224.
14. Kendall P.C., Finch A.J., Auerbach S.M., Hooke J.F., Mikulka P.J. The State-trait Anxiety Inventory: a systematic evaluation. J Consult Clin Psychol 1976, 44:406-412.
15. Lieb K., Frauenknecht S., Brunnhuber S. Psychiatrie und Psychotherapie 2009, Urban and Fischer; Elsevier, Munich, G, p. 4-5.
16. Van Tricht M.J., Dreissen Y.E., Cath D., Dijk J.M., Contario M.F., van der Slam S.M., et al. Cognition and psychopathology in myoclonus-dystonia. J Neurol Neurosurg Psychiatry 2012, 83:814-820.
17. Doheny D.O., Brin M.F., Morrison C.E., Smith C.J., Walker R.H., Abbasi S., et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002, 59:1187-1196.
18. Roze E., Apartis E., Clot F., Dorison N., Thobois S., Guyant-Marechal L., et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008, 70:1010-1016.
19. Wong S.H., Steiger M.J., Larner A.J., Fletcher N.A. Hereditary myoclonus dystonia (DYT11): a novel SGCE gene mutation with intrafamilial phenotypic heterogeneity. Mov Disord 2010, 25:956-957.
20. Misbahuddin A., Placzek M., Lennox G., Taanman J.W., Warner T.T. Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Mov Disord 2007, 22:1173-1175.
21. Hess C.W., Raymond D., Aguiar Pde C., Frucht S., Shriberg J., Heiman G.A., et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 2007, 68:522-524.
22. Contarino M.F., Foncke E.M., Cath D.C., Schuurman P.R., Speelman J.D., Tijssen M.A. Effect of pallidal deep brain stimulation on psychiatric symptoms in myoclonus-dystonia due to epsilon-sarcoglycan mutations. Arch Neurol 2011, 68:1087-1088.
23. Servello D., Sassi M., Brambilla A., Porta M., Haq I., Foote K.D., et al. De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report. J Neurol 2009, 256:1533-1539.
24. Benkert O., Wetzel H., Szegedi A. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder. Int Clin Psychopharmacol 1993, (8 Suppl. 1):3-14.
25. Van Hove J.L., Steyaert J., Matthijs G., Legius E., Theys P., Wevers R., et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry 2006, 77:18-23.
26. Tadic V., Kasten M., Bruggemann N., Stiller S., Hagenah J., Klein C. Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Arch Neurol 2012, 17:1-5.
27. Asanuma K., Ma Y., Okulski J., Dhawan V., Chaly T., Carbon M., et al. Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 2005, 64:347-349.
28. Beukers R.J., Booij J., Weisscher N., Zijlstra F., van Amelsvoort T.A., Tijssen M.A. Reduced striatal D2 receptor binding in myoclonus-dystonia. Eur J Nucl Med Mol Imaging 2009, 36:269-274.
29. Morrow E.M., Yoo S.Y., Flavell S.W., Kim T.K., Lin Y., Hill R.S., et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
30. Kumar K.R., Lohmann K., Klein C. Genetics of Parkinson disease and other movement disorders. Curr Opin Neurol 2012, 25:466-474.